Therefore, in order to reduce the adverse reaction of liver injury, the treatment concentration of (+)-UA on cells should be lower than 10 μM. Nevertheless, there is still no research that involves whether or not the treatment of c-KIT(+) CRC cells with (+)-UA (<10 μM) can inhibit SCF-mediated cells migration. The gene discussed is KIT; the disease is colorectal carcinoma.